Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MERIT MEDICAL SYSTEMS INC Director's Dealing 2021

Jun 22, 2021

31049_dirs_2021-06-21_cc993685-982e-40a1-9b51-c7448bd7aad7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MERIT MEDICAL SYSTEMS INC (MMSI)
CIK: 0000856982
Period of Report: 2021-06-17

Reporting Person: ANDERSON A SCOTT (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-06-17 Common Stock, No Par Value A 2914 Acquired 47085 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Non-qualified stock options (right to buy) $18.8 2023-05-26 Common Stock (5000) 5000 Direct
Non-qualified stock options (right to buy) $34.4 2024-05-24 Common Stock (10000) 10000 Direct
Non-qualified stock options (right to buy) $50.5 2025-06-07 Common Stock (25000) 25000 Direct
Non-qualified stock options (right to buy) $52.17 2026-05-24 Common Stock (13750) 13750 Direct
Non-qualified stock options (right to buy) $52.17 2026-05-31 Common Stock (7500) 7500 Direct

Footnotes

F1: The reported transaction involved the reporting person's receipt of a grant of 2,914 restricted stock units under the Merit Medical System, Inc. 2018 Long-Term Incentive Plan. The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 of Table I includes the 2,914 newly awarded restricted stock units that vest on June 17, 2022, 4,188 previously reported time-vesting restricted stock units that vest on June 22, 2021, and 39,983 shares of common stock. Vesting of restricted stock units is subject to continued service to the issuer through the vesting date.

F2: Becomes exercisable in equal annual installments of 20% commencing 05/26/2017.

F3: Becomes exercisable in equal annual installments of 20% commencing 05/24/2018.

F4: Becomes exercisable in equal annual installments of 20% commencing 06/07/2019.

F5: Becomes exercisable in equal annual installments of 33% commencing 05/24/2020.

F6: Becomes exercisable in equal annual installments of 33% commencing 05/31/2020.